Consolidated Statement of Changes in Net Equity

For details see Note (25) ‟Equity”.

31 KB EXCEL

  Equity capital   Retained earnings   Gains/losses recognized in equity  
€ million General partner’s equity Merck KGaA Subscribed capital Merck KGaA Capital reserves (share premium) Merck KGaA Retained earnings/Net retained profit Remeasurement of defined benefit plans Available-for-sale financial assets Derivative financial instruments Currency translation difference Equity attributable to Merck KGaA shareholders Non-controlling interests Total equity
Balance as of January 1, 2016 397 168 3,814 7,025 – 1,160 5 – 176 2,714 12,787 68 12,855
Profit after tax 1,629 1,629 4 1,633
Other comprehensive income – 344 19 – 15 515 175 2 177
Comprehensive income 1,629 – 344 19 – 15 515 1,804 6 1,810
Dividend payments – 136 – 136 – 3 – 139
Profit transfer to/from E. Merck KG including changes in reserves – 466 – 466 – 466
Transactions with no change of control
Changes in scope of consolidation/Other – 3 3 – 10 – 10
Balance as of December 31, 2016 397 168 3,814 8,049 – 1,501 24 – 191 3,229 13,989 61 14,050
                       
Balance as of January 1, 2017 397 168 3,814 8,049 – 1,501 24 – 191 3,229 13,989 61 14,050
Profit after tax 2,600 2,600 10 2,610
Other comprehensive income 142 7 69 – 2,057 – 1,839 – 4 – 1,843
Comprehensive income 2,600 142 7 69 – 2,057 761 6 767
Dividend payments – 155 – 155 – 4 – 159
Profit transfer to/from E. Merck KG including changes in reserves – 593 – 593 – 593
Transactions with no change of control
Changes in scope of consolidation/Other 1 1 1
Balance as of December 31, 2017 397 168 3,814 9,901 – 1,358 31 – 121 1,171 14,003 63 14,066